Connectivity Map 100k
Connectivity Map 100k
批准号:
7943084
负责人:
TODD R. GOLUB
金额:
$96.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-29 至 2012-07-31
关键词:
AddressBiologicalBiologyBiomedical ResearchChemicalsClinicalClinical TrialsCommunitiesDataData SetDatabasesDependenceDevelopmentDiseaseDrug effect disorderFDA approvedFoundationsFutureGene ExpressionGenerationsGenesGeneticGenomeGenomicsGoalsHumanLaboratoriesLanguageLinkMapsMethodsMolecular ProfilingMusPathway interactionsPatternPharmaceutical PreparationsPhaseProductionProteinsProtocols documentationResearchResearch InfrastructureResearch PersonnelResourcesScientistTherapeutic Effectbasecell typecostdata managementdistributed datadrug discoveryforginggenetic profilingknock-downnovelnovel strategiesplatform-independentprogramsresearch studysmall moleculetooluser-friendlyweb interface
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): PROJECT SUMMARY: The Connectivity Map 100k project aims to forge a path toward a comprehensive 'functional look-up table' that that links disease biology, genome function and small-molecule action. Such a Connectivity Map would enable researchers worldwide to generate testable hypotheses that might otherwise remain undiscovered. By using genomic signatures as a common language with which to describe different cellular states, a broad range of research applications would be enabled. We propose here an ambitious plan to generate 100,000 Connectivity Map profiles of genetic and pharmacologic perturbation that will serve two important purposes. First, it will generate an expanded Connectivity Map database that will further support biological discovery. Second, it will establish the parameters for a future, larger scale Connectivity Map resource that might include, for example, profiles of perturbation of all human and mouse genes plus hundreds of thousands of small-molecules in a large number of cell types. In Aim 1, we will extend our pilot pharmacologic Connectivity Map data to genetic perturbations. Specifically, we will use lentiviral shRNAs to knock down the expression of 1,000 human genes in 10 diverse cell types. These experiments will establish the feasibility of developing large-scale signatures of genetic perturbation, and will establish the extent of cellular context-dependence of the observed connections. In Aim 2, we will generate profiles of 1,500 small-molecules (a blend of FDA-approved drugs and tool compounds being studied in NIH-sponsored chemical biology programs), again in 10 diverse cell types. By the end of this 2-year project, we expect a) to have generated 100,000 perturbational profiles made publicly accessible via a user-friendly web interface, and b) to have laid the foundation for the creation of a future, community-based, large-scale Connectivity Map public resource. RELEVANCE The proposed project is expected to have significant impact on a broad range of the biomedical research community. It has the potential to yield new approaches to genome functional annotation, to provide a path toward the elucidation of mechanism-of-action of small-molecule compounds, and to facilitate the discovery of drugs with unanticipated therapeutic effects on disease biology.
PUBLIC HEALTH RELEVANCE: NARRATIVE: The Connectivity Map 100k project aims to forge a path toward a comprehensive 'functional look-up table' that links disease biology, genome function and small-molecule action. Through the generation of a database of 100,000 gene expression profiles of genetic and pharmacologic perturbation, the Connectivity Map will enable the biomedical community with a set of tools that facilitate systematic discoveries that link disease biology, genome biology and chemical biology. The proposed project will lay the groundwork for a future, large-scale, community-wide effort to create a public Connectivity Map resource that spans diverse perturbational profiles across a large number of cell types.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovering existing medicines that abrogate cellular responses to SARS CoV-2 infection
-
批准号:10199270
-
项目类别:
-
资助金额:$165.28万
-
财政年份:2020
-
负责人:TODD R. GOLUB
-
依托单位:
Making cancer precision medicine real: bottlenecks and opportunities
-
批准号:10473781
-
项目类别:
-
资助金额:$100.38万
-
财政年份:2019
-
负责人:TODD R. GOLUB
-
依托单位:
Making cancer precision medicine real: bottlenecks and opportunities
-
批准号:10018814
-
项目类别:
-
资助金额:$102.43万
-
财政年份:2019
-
负责人:TODD R. GOLUB
-
依托单位:
Making cancer precision medicine real: bottlenecks and opportunities
-
批准号:9816920
-
项目类别:
-
资助金额:$102.43万
-
财政年份:2019
-
负责人:TODD R. GOLUB
-
依托单位:
Making cancer precision medicine real: bottlenecks and opportunities
-
批准号:10246428
-
项目类别:
-
资助金额:$84.44万
-
财政年份:2019
-
负责人:TODD R. GOLUB
-
依托单位:
Making cancer precision medicine real: bottlenecks and opportunities
-
批准号:10687086
-
项目类别:
-
资助金额:$100.38万
-
财政年份:2019
-
负责人:TODD R. GOLUB
-
依托单位:
LINCS Data Coordination and Integration Center
-
批准号:9096857
-
项目类别:
-
资助金额:$66.88万
-
财政年份:2015
-
负责人:TODD R. GOLUB
-
依托单位:
LINCS Data Coordination and Integration Center
-
批准号:8825090
-
项目类别:
-
资助金额:$66.88万
-
财政年份:2015
-
负责人:TODD R. GOLUB
-
依托单位:
LINCS Data Coordination and Integration Center
-
批准号:9280623
-
项目类别:
-
资助金额:$66.88万
-
财政年份:2015
-
负责人:TODD R. GOLUB
-
依托单位:
PQB-3: Discovery and validation of the driving mediators of cancer cachexia
-
批准号:8792102
-
项目类别:
-
资助金额:$55.44万
-
财政年份:2014
-
负责人:TODD R. GOLUB
-
依托单位:
Broad Institute LINCS Center for Transcriptomics
-
批准号:8787845
-
项目类别:
-
资助金额:$209.28万
-
财政年份:2014
-
负责人:TODD R. GOLUB
-
依托单位:
Broad Institute LINCS Center for Transcriptomics
-
批准号:9098784
-
项目类别:
-
资助金额:$210.7万
-
财政年份:2014
-
负责人:TODD R. GOLUB
-
依托单位:
PQB-3: Discovery and validation of the driving mediators of cancer cachexia
-
批准号:9333287
-
项目类别:
-
资助金额:$58.56万
-
财政年份:2014
-
负责人:TODD R. GOLUB
-
依托单位:
Broad Institute Center for Cancer Systems Biology
-
批准号:8444659
-
项目类别:
-
资助金额:$200.61万
-
财政年份:2013
-
负责人:TODD R. GOLUB
-
依托单位:
Broad Institute Center for Cancer Systems Biology
-
批准号:8628529
-
项目类别:
-
资助金额:$6.87万
-
财政年份:2013
-
负责人:TODD R. GOLUB
-
依托单位:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
-
批准号:8654308
-
项目类别:
-
资助金额:$69.37万
-
财政年份:2013
-
负责人:TODD R. GOLUB
-
依托单位:
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
-
批准号:8494195
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2013
-
负责人:TODD R. GOLUB
-
依托单位:
Broad Institute Center for Cancer Systems Biology
-
批准号:8340111
-
项目类别:
-
资助金额:$203.27万
-
财政年份:2011
-
负责人:TODD R. GOLUB
-
依托单位:
Large scale gene expression analysis of cellular states
-
批准号:8150481
-
项目类别:
-
资助金额:$232.26万
-
财政年份:2010
-
负责人:TODD R. GOLUB
-
依托单位:
Large scale gene expression analysis of cellular states
-
批准号:8254069
-
项目类别:
-
资助金额:$8.84万
-
财政年份:2010
-
负责人:TODD R. GOLUB
-
依托单位:
海外基金